Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. - Wikidata - awgldk - TriplyDB

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.

http://www.wikidata.org/entity/Q39187631

about

Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology New Concepts in Malaria Pathogenesis: The Role of the Renin-Angiotensin System Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges AT2 Receptors: Potential Therapeutic Targets for Hypertension.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.Enhanced activity of an angiotensin-(1-7) neuropeptidase in glucocorticoid-induced fetal programming Renin-angiotensin system in the kidney: What is new?An angiotensin-(1-7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme.Structural libraries of protein models for multiple species to understand evolution of the renin-angiotensin system.Angiotensin type 2 receptors: blood pressure regulation and end organ damage Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Role of non-classical renin-angiotensin system axis in renal fibrosis.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Alamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissue Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems.Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.Protective axis of the renin-angiotensin system in the brain.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system.Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.Fluorescence-Based Binding Assay for Screening Ligands of Angiotensin Receptors.ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome.Novel Pathophysiological Mechanisms in Hypertension.Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice.The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy.

P2860

Q26742054-0F1E780E-8370-46E1-9834-4676BB56F54F Q26771362-F6977AB6-D785-4707-AB0F-9AB385CC7506 Q26798487-C325F547-235D-4077-AC70-ABD51CCC7CE9 Q26823573-D1D68F03-ECB2-4E6A-8122-836E646BE6DA Q30275852-4D84A0F7-B2C7-4174-B00F-5343D6100ABF Q30486707-0D90DCA9-F5CB-4CEA-899B-6F398E1164BD Q33554921-3230C1E5-9836-48F8-A93D-2AA499CF9029 Q33784943-98AA2DEB-C215-4DFC-94FE-69BFF2BB346D Q34001678-423A9C8B-48DA-4FBC-8072-BDC200F01BB6 Q34147653-2E85F652-8960-4BBE-B085-B8F1C6EC867D Q34367671-C3351CE8-F3B7-4365-9D5C-9A1EF3C09CD1 Q35178620-68FF2008-FC40-467A-9F69-C2301C50AC7A Q35220595-432A9D02-1060-4458-941D-3E627179421D Q35236405-A10437D7-1920-4265-BA0B-3FAE2EA10787 Q35484295-C22F8697-14C3-4D2A-897A-68AB21923FCA Q35506543-3391FACA-B529-4285-B4D5-E26AF732619B Q36241932-F2CBC840-59D0-4A58-AAA5-E90DD83A4D54 Q36395019-ECF31523-642F-4BD3-9DC5-05AF36C7D9A6 Q36699651-CF3D6345-0EBB-4609-A622-787D53151EFB Q37293326-C01E37B7-9E05-4823-A0F0-87FDD68C8B03 Q37454928-459729EF-DC13-4121-9D22-9AC8F58E4A81 Q37592161-5D95E50A-6D57-4E5F-9AD0-7CB215A71D04 Q38110197-B55059BE-E508-4628-A18A-6390F8DE5547 Q38193206-57B4971E-0610-4A68-A578-58BBC24A7C8C Q38206729-C56D371E-AD6B-4137-8E2D-A6EF7A346041 Q38211744-BB4483B4-0009-4823-8802-5A27E94F8EFB Q38217456-A38D0E40-4CCF-4106-8758-29F9D9BE5A0C Q38230104-E41DDCD9-3FFD-4E18-A66D-769DB91E111C Q38317550-05BEC7DF-BB5A-496A-ABB8-1DAE9BA2C756 Q38370816-BC87BC5B-64B2-42AC-BB85-C60F8D87E001 Q38567063-32C5A52D-44F0-4963-AF6F-B4AF83AF1EAC Q38750210-A742BDA3-E0D6-40FF-BB91-256AE77EC959 Q38846247-6AE67D52-35E6-41DB-BC91-756CFEF359B8 Q38979226-3331E785-3374-4145-B501-D4CF99179D9E Q39040850-91FD61BB-BCFB-44A6-8C29-AC79638ED6DB Q39134595-BA2088FC-BD02-4372-BD66-C51F719F2558 Q39340422-9E823194-0514-424E-9E06-B2FCDB9BBD50 Q39376362-E19EF973-F78C-4DE0-B5DD-3F830DBE296F Q39416346-D56F57DF-6C9B-41B1-ABA0-89044E42F065 Q41717344-2D2ECC68-AC3C-413C-B147-AF7BA788057E

P2860

Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.

http://www.wikidata.org/entity/Q39187631

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Discovery and characterization ...... the renin-angiotensin system.

@en

Discovery and characterization ...... the renin-angiotensin system.

@nl

type

label

Discovery and characterization ...... the renin-angiotensin system.

@en

Discovery and characterization ...... the renin-angiotensin system.

@nl

prefLabel

Discovery and characterization ...... the renin-angiotensin system.

@en

Discovery and characterization ...... the renin-angiotensin system.

@nl

P1433

Q39187631-E2506CD6-F624-4833-959D-906F3452D036

P1476

Q39187631-E7E8D332-4C2E-4AB5-AED2-24B9C2B45639

P2093

Q39187631-0D11DE18-EA2C-4BA1-9FA3-0BB4B68B60CA

Q39187631-113F65A6-F177-4332-91E2-679E25837A76

Q39187631-14B8B0C4-AAD3-46DB-A138-722A9ECDFB44

Q39187631-1F8131A8-5D49-4972-A88F-DAD1985B6385

Q39187631-32E12293-1904-4C85-BE18-E3FBD5FA0C3A

Q39187631-35482C66-1673-449C-A509-611EF4BE3A52

Q39187631-396E9F95-2605-4246-A0A2-8561EA9488D1

Q39187631-4A9D864A-B7D2-4131-9103-E30726B5061C

Q39187631-52CFC23C-C928-458D-A531-D4C1DF6129CA

Q39187631-585C27C2-A396-4F8A-852F-B5689B014413

P304

Q39187631-BB91A38E-2BED-4EB5-84ED-4B1A092E7C75

P31

Q39187631-EF605E95-2FD6-4B35-B6BA-D4477A70D0C6

P356

Q39187631-ADD82CC4-381F-4095-AED4-6003ABA0C3AD

P433

Q39187631-6DF53E2A-3832-418D-8D7D-57A97EE8706F

P478

Q39187631-BDDC8D33-396C-4167-AD22-03778A68A925

P50

Q39187631-404E4C63-C5BA-42C2-94EE-72E3FC85DC18

Q39187631-553560B9-5759-4056-8C6B-89E32B7D16B5

Q39187631-7E7F0E74-7C87-4E4F-90E1-D688C173C36B

Q39187631-89EDEA31-4DA5-4F47-A869-E16340A294CD

Q39187631-9A0E5CDF-4AD4-452E-A070-C2152D90476D

P577

Q39187631-0586E99D-DD8F-4588-854E-0798869CE0E6

P5875

Q39187631-18511C40-422F-4DFC-85A9-2440A90D75F3

P698

Q39187631-BB44715B-4845-44A9-86F1-011E83B66C74

P356

CIRCRESAHA.113.301077

P1433

Circulation Research

P1476

Discovery and characterization ...... the renin-angiotensin system.

@en

P2093

Adriano Pimenta

http://www.w3.org/2001/XMLSchema#string

Aline Oliveira

http://www.w3.org/2001/XMLSchema#string

Almir Martins

http://www.w3.org/2001/XMLSchema#string

Anderson Ferreira

http://www.w3.org/2001/XMLSchema#string

Andreia Alzamora

http://www.w3.org/2001/XMLSchema#string

Antonio Bastos Peluso

http://www.w3.org/2001/XMLSchema#string

Claudiane Barbosa

http://www.w3.org/2001/XMLSchema#string

Daniel C Villela

http://www.w3.org/2001/XMLSchema#string

Danielle Passos-Silva

http://www.w3.org/2001/XMLSchema#string

Everton Soares

http://www.w3.org/2001/XMLSchema#string

P304

1104-1111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.113.301077

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Thiago Verano-Braga

Maria José Campagnole-Santos

P577

2013-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235750191

http://www.w3.org/2001/XMLSchema#string

P698

23446738

http://www.w3.org/2001/XMLSchema#string